Caricamento...
Systemic Absorption of Rifamycin SV MMX Administered as Modified-Release Tablets in Healthy Volunteers
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages over the existing immediate-release antidiarrheic formulations. In two pharmacokinetics studies of healthy volunteers, the absorption, urinar...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3088207/ https://ncbi.nlm.nih.gov/pubmed/21402860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01504-10 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|